| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.11. | CeriBell gets FDA nod for neonate seizure detection algorithm | 2 | MassDevice | ||
| 24.11. | Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates | 1 | GlobeNewswire (USA) | ||
| 05.11. | CeriBell raises 2025 revenue guidance to $89M while targeting deeper hospital penetration and expanding pediatric market | 1 | Seeking Alpha | ||
| 04.11. | Ceribell Reports Third Quarter 2025 Financial Results | 94 | GlobeNewswire (Europe) | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| 04.11. | Ceribell, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 04.11. | Ceribell, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 21.10. | Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 | 2 | GlobeNewswire (USA) | ||
| 20.10. | Raymond James stuft Ceribell mit "Strong Buy" ein - Kursziel bei 19 $ | 6 | Investing.com Deutsch | ||
| CERIBELL Aktie jetzt für 0€ handeln | |||||
| 20.10. | Raymond James initiates Ceribell stock with Strong Buy rating, $19 target | 2 | Investing.com | ||
| 24.09. | Ceribell erweitert Liefervereinbarung um Produktionspartner in Vietnam | 4 | Investing.com Deutsch | ||
| 22.09. | Former Silk Road Medical CEO joins CeriBell's board | 1 | MassDevice | ||
| 22.09. | Ceribell, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.09. | Ceribell appoints former Silk Road Medical CEO to board of directors | 2 | Investing.com | ||
| 22.09. | Medtech Leader Erica Rogers Joins Ceribell Board of Directors | 1 | GlobeNewswire (USA) | ||
| 27.08. | Natus Medical denies CeriBell's brain EEG patent infringement claim | 2 | MassDevice | ||
| 06.08. | CeriBell GAAP EPS of -$0.38 beats by $0.02, revenue of $21.2M beats by $0.75M | 1 | Seeking Alpha | ||
| 06.08. | Ceribell outlines $85M-$88M 2025 revenue target while expanding pediatric and neonate pilots | 1 | Seeking Alpha | ||
| 05.08. | Ceribell, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.08. | Ceribell, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.07. | Ceribell, Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,220 | +0,44 % | EQS-News: mAbxience und HP treiben den Einsatz künstlicher Intelligenz bei der Bioproduktion und der Entwicklung von Biosimilars voran | EQS-News: mAbxience
/ Schlagwort(e): Joint Venture/Produkteinführung
mAbxience und HP treiben den Einsatz künstlicher Intelligenz bei der Bioproduktion und der Entwicklung von... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 43,580 | +0,65 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| DRAEGERWERK | 67,80 | -0,73 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| MEDTRONIC | 87,65 | +0,03 % | FDA Clears Medtronic's Hugo Robotic-Assisted Surgery System For Urologic Procedures | WASHINGTON (dpa-AFX) - Medtronic (MDT) announced that it has received FDA clearance for its Hugo robotic-assisted surgery (RAS) system in urologic procedures, marking a significant milestone... ► Artikel lesen | |
| INTUITIVE SURGICAL | 487,35 | -0,23 % | Intuitive Surgical, Inc. (ISRG): A Bull Case Theory | ||
| TELADOC HEALTH | 6,692 | +0,09 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| THERMO FISHER | 490,80 | -0,63 % | IN BRIEF: GENinCode inks commercialisation deal with Thermo Fisher | ||
| ROKU | 79,48 | -2,15 % | NextTrip, Inc.: NextTrip's JOURNY Expands Global Reach with Launch on Apple iOS, Roku, and Android | New Apps Deepen Audience Engagement and Extend JOURNY's Rebrand Momentum Across Major Platforms SANTA FE, NEW MEXICO / ACCESS Newswire / December 4, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip,"... ► Artikel lesen | |
| HIMS & HERS HEALTH | 34,600 | +0,64 % | Hims & Hers expands into diagnostics, moves into Canada as it evolves DTC telehealth platform | ||
| SERNOVA BIOTHERAPEUTICS | 0,091 | +3,41 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| DEXCOM | 55,89 | -0,30 % | DexCom, Inc.: Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy | New personalised learning platform aims to build confidence in healthcare professional (HCP) CGM knowledge, no matter their previous experience, and support high-quality diabetes care. ... ► Artikel lesen | |
| ALCON | 69,50 | +2,42 % | Alcon: Wachstum beschleunigt sich wieder - Übernahme wackelt | Die Aktie von Alcon erlebt bisher ein schwieriges Jahr 2025. Die Zahlen für das dritte Quartal sorgten endlich für neuen Schwung, der Kurs stieg kräftig an. Es gibt aber auch schlechte Nachrichten:... ► Artikel lesen | |
| RESMED | 222,70 | +3,10 % | Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed | WASHINGTON (dpa-AFX) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments.Sensei... ► Artikel lesen | |
| HEALWELL AI | 0,594 | +1,98 % | HEALWELL verzeichnet Rekordumsatzwachstum in 3. Quartal und ist nun reines globales SaaS-, Service- und KI-Unternehmen für Gesundheitssysteme und Biowissenschaften | - HEALWELL erzielte im dritten Quartal 2025 einen Quartalsumsatz aus fortlaufenden Betrieben in Höhe von 30,4 Millionen $ - eine Steigerung von 354 % gegenüber dem Umsatz von
6,7 Millionen... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 35,430 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |